27855629|t|Vitamin D and the Epigenetic Machinery in Colon Cancer
27855629|a|Vitamin D is an important hormone that regulates many physiological processes related to human health. Through its nuclear receptor, VDR, vitamin D controls gene expression through genetic and epigenetic mechanisms. Increasing data have demonstrated the anti-cancer activities of vitamin D in various cancers, including colon cancer. This review summarizes the recent progresses in our understanding of the molecular mechanisms of vitamin D and its interaction with the epigenetic machinery in colon cancer. Vitamin D changes the status of DNA methylation and histone modification s, resulting in the activation of tumor suppressors and inhibition of oncogenes. In addition, vitamin D activates the expression of tumor suppressing miRNAs, which contribute to the tumor suppressive activity. Further understanding of the epigenetic action of vitamin D will help the development of therapeutic strategies targeting the vitamin D signaling pathway without inducing the hypercalcemic side effects.
27855629	0	9	Vitamin D	T109,T121,T127	C0042866
27855629	18	38	Epigenetic Machinery	T045	C1516924
27855629	42	54	Colon Cancer	T191	C0699790
27855629	55	64	Vitamin D	T109,T121,T127	C0042866
27855629	81	88	hormone	T125	C0019932
27855629	94	103	regulates	T038	C1327622
27855629	109	132	physiological processes	T039	C0031845
27855629	144	149	human	T016	C0086418
27855629	150	156	health	T078	C0018684
27855629	170	186	nuclear receptor	T116,T192	C0206588
27855629	188	191	VDR	T116,T192	C3657722
27855629	193	202	vitamin D	T109,T121,T127	C0042866
27855629	212	227	gene expression	T045	C0017262
27855629	236	243	genetic	T169	C0314603
27855629	248	269	epigenetic mechanisms	T045	C1516924
27855629	282	286	data	T078	C1511726
27855629	309	331	anti-cancer activities	T033	C0243095
27855629	335	344	vitamin D	T109,T121,T127	C0042866
27855629	356	363	cancers	T191	C0006826
27855629	375	387	colon cancer	T191	C0699790
27855629	394	400	review	T170	C0282443
27855629	423	433	progresses	T169	C1280477
27855629	462	482	molecular mechanisms	T044	C1258062
27855629	486	495	vitamin D	T109,T121,T127	C0042866
27855629	504	515	interaction	T169	C1704675
27855629	525	545	epigenetic machinery	T045	C1516924
27855629	549	561	colon cancer	T191	C0699790
27855629	563	572	Vitamin D	T109,T121,T127	C0042866
27855629	585	591	status	T080	C0449438
27855629	595	610	DNA methylation	T044	C0376452
27855629	615	635	histone modification	T044	C1156199
27855629	639	648	resulting	T169	C1274040
27855629	656	666	activation	T052	C1879547
27855629	670	687	tumor suppressors	T028	C0079427
27855629	692	702	inhibition	T052	C3463820
27855629	706	715	oncogenes	T028	C0029016
27855629	730	739	vitamin D	T109,T121,T127	C0042866
27855629	740	749	activates	T052	C1879547
27855629	754	764	expression	T045	C0017262
27855629	768	785	tumor suppressing	T028	C0079427
27855629	786	792	miRNAs	T114,T123	C1101610
27855629	818	844	tumor suppressive activity	T043	C1325410
27855629	875	892	epigenetic action	T045	C1516924
27855629	896	905	vitamin D	T109,T121,T127	C0042866
27855629	920	931	development	T169	C1527148
27855629	935	946	therapeutic	T169	C0302350
27855629	947	957	strategies	T041	C0679199
27855629	958	967	targeting	T169	C1521840
27855629	972	999	vitamin D signaling pathway	T044	C2753317
27855629	1021	1034	hypercalcemic	T047	C0020437
27855629	1035	1047	side effects	T169	C0001688